SECsense Logo

Werewolf Therapeutics, Inc. 8-K Report: Key Event on February 19, 2025

$HOWL
Form 8-K
Filed on: 2025-02-24
Source
Werewolf Therapeutics, Inc. 8-K Report: Key Event on February 19, 2025

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Werewolf Therapeutics, Inc.
  • CIK Number: 0001785530
  • SEC File Number: 001-40366
  • IRS Number: 82-3523180
  • Address: 200 Talcott Ave, 2nd Floor, Watertown, MA 02472
  • Contact Number: (617) 952-0555
  1. Filing Type:
  • Form Type: 8-K (which is a report of unscheduled material events or corporate changes that could be of importance to shareholders).
  1. Financial Details:
  • Common Stock Par Value: $0.0001 per share.
  • Ticker Symbol: HOWL (traded on NASDAQ).
  1. Reporting Period:
  • Date of Report: February 19, 2025.
  • Period Covered: The report reflects a specific event on February 19, 2025.
  1. XBRL Metadata:
  • The report is structured using XBRL (eXtensible Business Reporting Language), which is a format for transmitting financial data.

Insights:

  • The company is likely announcing a significant event or update on February 19, 2025, as per the requirements of the 8-K filing.
  • The low par value of the common stock suggests that the company may be in a growth or emerging stage, typically seen in biotech or pharmaceutical firms.
  • The information provided indicates that the company is compliant with SEC filing requirements and is making use of digital reporting standards (XBRL), which enhances transparency and accessibility of financial information.

Conclusion:

This section of the financial report provides critical information about Werewolf Therapeutics, Inc., specifically in regard to a notable event or change as reported on February 19, 2025. Investors and stakeholders should monitor this filing for any material impacts on the company’s operations or financial health that could affect stock performance.